Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol in Symptomatic Oral Lichen Planus
NCT04364555Phase 3Active, not recruiting
- Sponsor
- Malmö University
- Start
- May 2020
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clobetasol in oral lichen planus (OLP), sponsored by Malmö University. Started May 2020; status: active, not recruiting.
02
Drugs
clobetasol
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT04364555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04364555.